A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

August 10, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

August 31, 2025

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Atezolizumab

Atezolizumab at a fixed dose of 1200 mg will be administered first by IV infusion Q3W on Day 1 of each 21-day cycle.

DRUG

Tiragolumab

Tiragolumab at a fixed dose of 600 mg will be administered by IV infusion Q3W on Day 1 of each 21-day cycle.

DRUG

Placebo

Placebo will be administered by IV infusion Q3W on Day 1 of each 21-day cycle.

Trial Locations (37)

333

Chang Gung Memorial Hospital - Linkou, Taoyuan District

1121

Taipei Veterans General Hospital, Taipei

8916

Hospital Univ Germans Trias i Pujol, Badalona

10002

National Taiwan University Hospital, Taipei

11000

Clinical Center of Serbia, Belgrade

11070

Clinical Hospital Center Bezanijska Kosa, Belgrade

13015

Hopital Nord AP-HM, Marseille

13620

Seoul National University Bundang Hospital, Gyeonggi-do

21079

Centre Georges François Leclerc, Dijon

22031

Virginia Cancer Specialists, PC, Fairfax

23561

Taipei Medical University ?Shuang Ho Hospital, New Taipei City

28036

Clinica Universitaria Navarra (Madrid), Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro - Majadahonda, Madrid

28644

Chungbuk National University Hospital, Cheongju-si

31008

Clinica Universitaria de Navarra, Pamplona

33076

Institut Bergonié Centre Régional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest, Bordeaux

33705

Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg

33901

SCRI Florida Cancer Specialists South, Fort Myers

35016

Complejo Hospitalario Universitario Insular?Materno Infantil, Las Palmas de Gran Canaria

41013

Centro Medico Quironsalud Sagrado Corazon, Seville

Hospital Universitario Virgen del Rocio, Seville

44115

Institut De Cancerologie De L'Ouest, Saint-Herblain

48201

Karmanos Cancer Institute, Detroit

49055

ICO Paul Papin, Angers

60005

Illinois Cancer Specialists, Arlington Heights

61615

Illinois Cancer Care, Peoria

64132

HCA Midwest Health, Kansas City

66205

University of Kansas Medical Center, Westwood

70403

National Cheng Kung University Hospital, North Dist.

85284

Arizona Oncology Associates, PC - HAL, Tempe

98684

Northwest Cancer Specialists - Vancouver, Vancouver

03181

Kangbuk Samsung Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

03010

Hospital General Universitario de Alicante, Alicante

08035

Hospital Universitario Vall d'Hebron - PPDS, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY